MAY 15·Stock Titan→
[6-K] GH Research PLC Current Report (Foreign Issuer) | GHRS SEC Filing - Form 6-K
GH Research PLC has announced an "at-the-market" equity offering sales agreement with Stifel, Nicolaus & Company to sell up to $200 million of ordinary shares. This offering will be conducted under an existing Form F-3 shelf registration. The company filed a prospectus supplement and an Irish legal opinion to support these potential sales, incorporating the report into several registration statements.
MAY 1·TipRanks→
GH Research Raises $111 Million in Completed Share Offering to Fund Depression Pipeline
GH Research (GHRS) successfully completed an underwritten public offering, raising approximately $111.2 million by selling 6,527,779 ordinary shares at $18.00 each. The capital will be used to advance the company's depression therapies, including research, clinical development, and pre-commercialization efforts for treatment-resistant depression therapies. This equity raise reflects investor confidence in GH Research's pipeline despite its current lack of revenue and widening losses, partly offset by a strong balance sheet.
